Hillrom Improves Hypertension Detection With New Welch Allyn® Spot Vital Signs® 4400 Device

CHICAGO , Feb. 3, 2020 - Global medical technology leader Hillrom today announced the commercial launch of the new Welch Allyn® Spot Vital Signs® 4400, an easy-to-use next-generation vital signs device ideal for ambulatory and emergency department settings.

Hillrom Announces Fiscal First Quarter Financial Results

CHICAGO, Jan. 24, 2020 - Hillrom (NYSE: HRC), today announced financial results for its fiscal first quarter ended December 31, 2019, confirmed its fiscal 2020 revenue guidance and raised the bottom of its adjusted earnings per diluted share guidance range.

Hillrom And The UK Sepsis Trust Announce Exclusive 2020 Sepsis Awareness Partnership

ASHBY DE LA ZOUCH, England, Jan. 23, 2020 - Global medical technology leader Hillrom (NYSE: HRC) and The UK Sepsis Trust today announced an exclusive, year-long partnership to raise greater awareness of sepsis. Throughout 2020 Hillrom will be working with The UK Sepsis Trust to provide awareness and training to hospitals on how they can use existing technology to help identify deteriorating patients more quickly.

Hillrom to Present at the 38th Annual J.P. Morgan Healthcare Conference

CHICAGO, Dec. 30, 2019 - Hillrom (NYSE: HRC), will present at the 38^th Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2020, in San Francisco. John Groetelaars, Hillrom's president and chief executive officer, is scheduled to present at 4:30 p.m. Pacific Time.

Hill-Rom Holdings, Inc., Nominates Felicia Norwood To Stand for Election to Its Board of Directors

CHICAGO, Dec. 20, 2019 - Hillrom (NYSE: HRC) today announced that its board of directors has nominated Felicia Norwood to stand for election as a director at the company's Annual Meeting of Shareholders on February 25, 2020. Ms. Norwood's successful election would raise the number of directors to 11.